2+ -activated Cl À channels (CaCCs) are gated open by a rise in intracellular Ca 2+ concentration ([Ca 2+ ] i ), typically provoked by activation of G q -protein coupled receptors (G q PCR). G q PCR activation initiates depletion of plasmalemmal phosphatidylinositol 4,5-bisphosphate (PIP 2 ). Here, we determined whether PIP 2 acts as a signalling lipid for CaCCs coded by the TMEM16A and TMEM16B genes.
Introduction
Calcium-activated chloride channels (CaCCs) are anion channels that are gated open in response to an increase in intracellular free Ca 2+ concentration ([Ca 2+ ] i ), and by changes in the cell membrane potential (V m ) towards depolarized values (Hartzell et al., 2005; Ferrera et al., 2011; Huang et al., 2012a) . Thus, CaCCs provide a link between Ca 2+ signalling and membrane electrical activity. CaCCs are present in a wide range of tissues and play diverse physiological roles including modulation of mucus secretion in epithelial cells, control of neuronal and cardiac excitability as well as modulation of smooth muscle contraction (Hartzell et al., 2005; Ferrera et al., 2011; Huang et al., 2012a) . The TMEM16 family encompasses genes coding for CaCCs, such as TMEM16A and TMEM16B, as well as a gene (TMEM16F) encoding a protein with reportedly combined ion channel and lipid scramblase activity (Pedemonte and Galietta, 2014; Picollo et al., 2015) . The TMEM16A and TMEM16B channels share significant (~55%) sequence homology and present similarities in their electrophysiological properties (Scudieri et al., 2011) . For example, TMEM16A and TMEM16B display very similar degrees of selectivity and permeability to a range of anions . Furthermore, the TMEM16A and TMEM16B channels are activated within overlapping ranges of [Ca 2+ ] i (e.g. Adomaviciene et al., 2013; Betto et al., 2014; Cruz-Rangel et al., 2015) . The TMEM16A and TMEM16B paralogues also share some pharmacological properties. For instance, both TMEM16A and TMEM16B are modulated in a complex manner by antracene-9-carboxilic acid (A9C) (Cherian et al., 2015; Ta et al., 2016) . These channels are inhibited by A9C via an open channel block mechanism while also being allosterically activated by the compound (Cherian et al., 2015; Ta et al., 2016) . TMEM16A and TMEM16B are also blocked by other commonly used Cl À channel blockers such as 4,4 0 -diisothiocyano-2,2 0 -stilbenedisulfonic acid (DIDS) and niflumic acid with comparable potencies (Bradley et al., 2014; Liu et al., 2015; Pifferi et al., 2009) . In contrast, a recently identified drug (Ani9) selectively inhibited TMEM16A, with no significant block of TMEM16B (Seo et al., 2016) .
TMEM16A and TMEM16B differ in terms of their expression profiles and physiological roles. TMEM16A is involved in functions such as transepithelial Cl À transport (Kunzelmann et al., 2012; Scudieri et al., 2012; Huang et al., 2012a) and in the modulation of smooth muscle tone Manoury et al., 2010; Thomas-Gatewood et al., 2011; Heinze et al., 2014; Wang et al., 2015) . Conversely, TMEM16B is chiefly involved in the control of sensory processes including olfaction and vision (Stephan et al., 2009; Stohr et al., 2009; Hengl et al., 2010; Pietra et al., 2016) and is expressed in neuronal and glial cells (Ayoglu et al., 2016) . In spite of participating in somewhat distinct physiological functions, TMEM16A and TMEM16B appear to be modulated by common signalling pathways. It is well established that activation of G q -protein coupled receptors, such as α 1 -adrenoceptors and P2Y receptors, leads to activation of phospholipase C (PLC) that breaks down phosphatidylinositol 4,5-bisphosphate (PIP 2 ) and leads to the formation of inositol triphosphate (IP 3 ). TMEM16A and TMEM16B channels can be activated by an IP 3 -mediated increase in [Ca 2+ ] i (Hartzell et al., 2005; Ferrera et al., 2011; Huang et al., 2012a) . Understanding whether agonistinduced changes in PIP 2 levels also participate in the control of the activity of TMEM16A and TMEM16B channels is an important question in the cellular physiology of CaCCs. Indeed, PIP 2 is known to modulate the activity of a variety of ion channel types (Suh and Hille, 2008; Hille et al., 2015) . A recent study presented biochemical evidence that PIP 2 binds to both cloned and native smooth muscle TMEM16A channels (Pritchard et al., 2014) . This study also included functional evidence that PIP 2 modulates native CaCC currents in rat isolated, pulmonary artery smooth muscle cells (rPASMCs). For instance, inclusion of diC8-PIP 2 , a water-soluble PIP 2 analogue, into the pipette solution led to a decrease in whole-cell CaCC current in rPASMCs. Thus, it was proposed that PIP 2 has an inhibitory effect on the native CaCC current in rPASMCs. Whether PIP 2 functionally modulates cloned TMEM16A channels remains to be established. Furthermore, the possible modulation of the closely related TMEM16B channels by PIP 2 has never been tested. Studying PIP 2 modulation of cloned TMEM16A and TMEM16B channels in a heterologous expression system allows the underlying molecular mechanism to be examined in the absence of additional tissue-specific modulatory pathways.
Here, we showed that cloned TMEM16A and TMEM16B channels are differentially modulated by PIP 2 , being activated and inhibited by this lipid respectively. The effect of PIP 2 on TMEM16A channels was especially pronounced in the low μM range of [Ca 2+ ] i and was observed at negative as well as positive V m . In contrast, the effects of PIP 2 on TMEM16B did not differ significantly over a wide range of [Ca 2+ ] i but was only detectable at highly depolarized V m (≥50 mV). Thus, PIP 2 may modulate TMEM16A under resting conditions as well as during membrane depolarization. In contrast, TMEM16B may be modulated only at highly depolarized V m , which might be reached by some types of excitable cells during action potential firing, especially during pathological conditions associated with elevations of the action potential peak. Identification of these new regulatory mechanisms highlights novel pathways for potential pharmacological intervention; small molecules that affect PIP 2 metabolism or directly interfere with PIP 2 binding/transduction on TMEM16A or TMEM16B channels could affect channel gating and serve as novel channel modulators.
Methods

Cell culture and transfection
This study involved (i) mouse TMEM16A [isoform (ac) (Caputo et al., 2008) (Tammaro and Ashcroft, 2009 ). HEK-293T cells were cultured as previously described and transfected with 0.6 μg of TMEM16A or TMEM16B, 1 μg of DrVSP or PIPK and 0.2 μg of CD8 constructs using Fugene HD (Promega, UK) according to the manufacturer's instructions. Cells were used 12-36 h after transfection. Transfected cells were visualized using the anti-CD8 antibody-coated beads method (Jurman et al., 1994) . Cells expressing CD8 were randomly selected for patch-clamp recordings.
Electrophysiology
TMEM16A and TMEM16B currents were measured with the whole-cell or inside-out configuration of the patch-clamp technique as detailed in the Supplementary Information.
Composition of solutions
The extracellular solution contained (mM): 150 NaCl, 1 CaCl 2 , 1 MgCl 2 , 10 glucose, 10 D-mannitol and 10 HEPES; pH was adjusted to 7.4 with NaOH. Ta et al., 2016) . To assess the sensitivity of TMEM16A and TMEM16B channels to diC8-PIP 2 during inside-out patch-clamp recordings (experiments of Figures 1 and 2 TMEM16A and TMEM16B currents measured in the presence of diC8-PIP 2 (I diC8-PIP2 ) were normalized to currents measured in the absence of diC8-PIP 2 (I 0 ) and plotted against diC8-PIP 2 concentration ([diC8-PIP 2 ]). As outlined in the Results section, TMEM16A and TMEM16B currents were activated and inhibited by diC8-PIP 2 respectively.
The [diC8-PIP 2 ]-response curves for TMEM16A were fitted with a Hill equation of the form
where A max is the maximal TMEM16A current activation, K a is the [diC8-PIP 2 ] at which activation is half-maximal and h is the Hill coefficient. The [diC8-PIP 2 ]-response curves for TMEM16B were fitted with a Hill equation of the form
where K i is the [diC8-PIP 2 ] at which inhibition is half maximal and j is the Hill coefficient.
Current versus V m relationship (I-V-tail protocol)
. Current versus V m relationships were constructed by measuring currents in response to V m steps of 1 s duration (test pulses) from À100 to +140 mV in 40 mV increments. Each test pulse was preceded by a V m step to +70 mV of 1 s duration (pre-pulse). Pulses were elicited every 2 s from a holding V m of 0 mV. Steady-state currents were measured at the end of the test pulses. For determination of the current reversal potential (E rev ), instantaneous currents were estimated from extrapolation of single exponential fits of the test-pulse currents to the beginning of each test pulse. These instantaneous current values were plotted as a function of the V m . The chord conductance and E rev were determined from the linear fit of the instantaneous I-V m relationship (Tammaro et al., 2005; Adomaviciene et al., 2013) .
Stationary noise analysis. Stationary noise analysis (DeFelice, 1981) assumes that there are N independent and identical channels with a single conducting level, i. The macroscopic current (I) is given by
From binomial theory, the variance, σ 2 , is related to I by
Tracts (1-5 s duration) of stationary currents were measured at +70 mV and in different [Ca 2+ ] i in both the absence and presence of diC8-PIP 2 . For each tract of current, the σ 2 and mean I were calculated. Background variance and current measured in 0 [Ca 2+ ] i were subtracted, and the σ 2 -I plot was fit with equation 4 with i and N as free parameters. Single channel conductance (γ) was calculated by dividing i by the V m at which the experiment was conducted . The σ 2 and I measured at each [Ca 2+ ] i were subsequently normalized for the estimated maximal current (I max , corresponding to P o = 1) and averaged. In this way, the ordinate represents σ 2 /I max and the abscissa represents P o .
Recovery of TMEM16A currents from DrVSP-mediated inhibition. A double-pulse protocol was used to determine the time required for the response of TMEM16A or TMEM16B currents to recover following DrVSP activation during a 4 s pulse to +100 mV (conditioning pulse). The conditioning pulse was followed by a varying recovery period (3 to 55 s) at À50 mV and a subsequent 4 s test pulse to +100 mV. The effect of DrVSP was assessed by measuring the difference between the peak (I p ) and the steady-state (I ss ) current elicited by each depolarizing pulse (I p À I ss ). The extent of recovery was expressed as the ratio of I p À I ss measured during a test pulse relative to that measured during the conditioning pulse. Time constant of recovery (τ r ) was obtained by fitting a single exponential function to the relationship between extent of recovery and the duration of the recovery period.
Data analysis
Data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . Electrophysiological data were analysed with routines developed in the IgorPro (Wavemetrics, OR, USA) environment. Methods of analysis were established during study design, and prior to execution of the experiments, to remove possible operator bias. Statistical significance was determined with two-tailed paired or unpaired t-tests or one-way ANOVA with Bonferroni's post test, as appropriate. For all statistical tests, P-values < 0.05 were considered significant. Data are given as mean ± SEM alongside the number of experiments (n). The SPSS (version 22; SPSS Inc., Chicago, IL, USA) or Excel (Microsoft, USA) programmes were used for statistical analysis.
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 .
Results
Sensitivity of TMEM16A and TMEM16B channels to diC8-PIP 2
The project began by testing the sensitivity of cloned TMEM16A channels to diC8-PIP 2 , a water soluble PIP 2 analogue frequently used to investigate the sensitivity of ion channels to PIP 2 (Suh and Hille, 2008; Hille et al., 2015) . TMEM16A currents were recorded in inside-out patches excised from transfected HEK-293T cells (Figure 1 channel activation (see below, Figure 2A ). When diC8-PIP 2 was applied to the intracellular side of the patch, the TMEM16A current increased in a dose-dependent manner up to a factor of 1.26 ± 0.04 (n = 12) in 100 μg·mL
À1
(117 μM) diC8-PIP 2 ( Figure 1 ). As described in greater detail below, the activating effect of PIP 2 on TMEM16A channels became much more pronounced in the presence of lower [Ca 2+ ] i . The TMEM16A sequence shares significant degree of homology with that of TMEM16B. We therefore tested the possibility that TMEM16B is also modulated by diC8-PIP 2 . Because TMEM16B channels are less sensitive to activation by [Ca 2+ ] i than TMEM16A channels Scudieri et al., 2013) , the [Ca 2+ ] i in these experiments was elevated to 1 μM, a value causing approximately halfmaximal activation in our experimental conditions ( Figure 2B ). In this way, the effect of diC8-PIP 2 could be compared under conditions that cause similar extent of activation of TMEM16A and TMEM16B currents. Surprisingly, it was found that diC8-PIP 2 100 μg·mL À1 (117 μM)
inhibited TMEM16B currents by up to a factor of 0.82 ± 0.02 (n = 9) ( Figure 1 Figure S1 ). diC8-PIP 2 inhibited the currents by a factor of 0.85 ± 0.02 (n = 9) in 0. 
45 ± 8 (n = 12) 53 ± 9 (n = 12) 1.2 ± 0.4 (n = 12) 1.4 ± 0.1 (n = 12)
A max , maximal extent of current activation; h, Hill coefficient; K a , diC8-PIP 2 concentration producing half-maximal activation of the channel (expressed in either in μg·mL À1 or in μM).
Table 2
Parameters obtained from the Hill fit of the relationship between the extent of TMEM16B current inhibition and [diC8-PIP 2 ]
39 ± 2 (n = 9) 46 ± 2 (n = 9) 1.1 ± 0.1 (n = 9) j, Hill coefficient; K i , diC8-PIP 2 concentration producing half-maximal inhibition of the channel (expressed in either in μg·mL À1 or in μM).
no detectable change in ≥2 μM [Ca 2+ ] i (Figure 2Aiii ). In contrast, γ of the TMEM16A channel was not affected by diC8-PIP 2 being~2.5 pS in both the absence and presence of the lipid (Figure 2Aiv ). Stationary noise analysis also revealed that diC8-PIP 2 caused reduction in P o of TMEM16B channels of a factor 0.87 ± 0.02 (n = 9), 0.85 ± 0.02 (n = 12) and 0.85 ± 0.02 (n = 21) in 0.6 μM, 1.0 μM and 2.0 μM [Ca 2+ ] i , respectively (Figure 2Biii ). The γ of the TMEM16B channel was~2 pS in both the absence and presence of diC8-PIP 2 (Figure 2Biv) . Thus, the changes in TMEM16A and TMEM16B current amplitudes caused by diC8-PIP 2 were due to changes in channel gating while γ was not affected.
Effects of V m on the sensitivity of TMEM16A and TMEM16B channels to diC8-PIP 2
We next tested the effects of diC8-PIP 2 at various V m . During inside-out patch-clamp, a pre-pulse of +70 mV was used to open TMEM16A or TMEM16B channels followed by a series of test pulses (I _ V tail protocol (Figure 3Ai) ). TMEM16A and TMEM16B currents were recorded in the presence of 0.3 μM and 0.6 μM [Ca 2+ ] i , respectively ( Figure 3Ai and Figure 3Bi ). basal activation of TMEM16B channels in our experimental conditions. The first observation was that the intracellular diC8-PIP 2 did not alter the E rev of TMEM16A or TMEM16B current. In the absence and presence of 100 μg·mL
À1
(117 μM) diC8-PIP 2 in the intracellular solution, the E rev of TMEM16A current was 3.1 ± 1.1 mV (n = 9) and 3.4 ± 0.4 mV (n = 9), respectively (Figure 3Aii ), and the E rev of TMEM16B was À1.3 ± 1.0 mV (n = 15) and À1.2 ± 1.4 mV (n = 15), respectively ( Figure 3Bii) . These values are very close to the expected E rev for Cl À in our recording conditions (~1 mV). Thus, diC8-PIP 2 did not alter the TMEM16A and TMEM16B channel selectivity to ions. The slope of the instantaneous current versus voltage relationship provides a measure of the conductance of the membrane. In the absence and presence of 100 μg·mL À1 (117 μM) diC8-PIP 2 in the intracellular solution, the membrane conductance for patches expressing TMEM16A was significantly increased from 1.3 ± 0.2 nS (n = 9) to 4.1 ± 0.8 nS (n = 9) (P < 0.05, paired t-test) while for patches expressing TMEM16B it was significantly decreased from 1.9 ± 0.2 nS (n = 15) to 1.6 ± 0.2 nS (n = 15) (P < 0.05, paired t-test).
It is noteworthy that the diC8-PIP 2 promoted an increase in TMEM16A steady-state current at all V m (Figure 3Aii ). In contrast, the inhibitory effect of diC8-PIP 2 on TMEM16B steady-state current was only observed at V m > 50 mV (Figure 3Bii) .
We finally examined the requirement for intracellular Ca 2+ in the development of the effects of diC8-PIP 2 on TMEM16A and TMEM16B currents. We found that in the absence of intracellular Ca
2+
(nominally Ca 2+ -free intracellular solution), diC8-PIP 2 exhibited no effect on the TMEM16A and TMEM16B currents at all tested V m ( Figure 3Aii , Bii and Suppl. Figure S2 for expanded version of the image). This indicates that the application of diC8-PIP 2 cannot lead to activation of TMEM16A channel in the absence of intracellular Ca 2+ . Furthermore, the data demonstrate a lack of inhibition of the small endogenous currents in cells transfected with TMEM16B and in Ca 2+ free solution.
Sensitivity of TMEM16A and TMEM16B channels to endogenous PIP 2
To test whether endogenous PIP 2 modulates TMEM16A and TMEM16B currents, cells were co-transfected with either TMEM16A or TMEM16B channels in conjunction with the membrane-localized protein Danio rerio voltage-sensitive phosphatase (DrVSP), which depletes endogenous PIP 2 content by dephosphorylation when V m is brought to depolarized values (Okamura et al., 2009) .
Initial control experiments were carried out in the absence of DrVSP. Under this condition, when V m was stepped to +100 mV for 4 s from the holding potential of À100 mV, large TMEM16A and TMEM16B whole-cell currents were elicited that reached a stable steady-state value ( Figure 4) . As previously reported, the TMEM16A currents activated more slowly than TMEM16B currents Scudieri et al., 2013; Cruz-Rangel et al., 2015) . The rate of TMEM16A and TMEM16B current activation was quantified by fitting the currents with a single exponential function with time constant τ f . The τ f for TMEM16A currents was~5 times greater than that for TMEM16B currents (Figure 4 , Table 3 ). This stimulation pulse was repeated three times, with 0.5 s intervals between each stimulation. During these stimulations, the kinetics of the TMEM16A and TMEM16B currents remained unchanged (Figure 4 and Table 3 ). The amplitude of the steady-state TMEM16A current was 473 ± 70 pA/pF (n = 8, first pulse); 473 ± 69 pA/pF (n = 8, second pulse) and 488 ± 69 pA/pF (n = 8, third pulse). The steady-state TMEM16B current was 113 ± 15 pA/pF (n = 8, first pulse); 114 ± 15 pA/pF (n = 8, second pulse) and 115 ± 16 pA/pF (n = 8, third pulse).
When cells were co-transfected with TMEM16A and DrVSP, the first depolarizing step to +100 mV elicited a whole-cell current with a biphasic component. In these experiments, the holding V m was À100 mV to maintain DrVSP inactive. During the depolarizing step, the current reached a maximal point [187 ± 53 pA/pF (n = 14)] and then relaxed to a lower amplitude steady-state level of 136 ± 39 pA/pF (n = 14) (Figure 4 ). This current was fitted with a double exponential function, with time constants τ f of~160 ms and τ s of~470 ms (Figure 4 and Table 3 ). The following two stimulations, however, gave rise to currents that were well described by a single exponential function with τ f of~130 ms (Table 3) and steady-state values of 137 ± 40 pA/pF (n = 14) and 138 ± 38 pA/pF (n = 14) respectively. These values were indistinguishable from the current amplitude of~136 pA/pF reached at the end of the first stimulus.
The same stimulation protocol was used to examine the current activation kinetics in HEK-293T cells co-transfected with TMEM16B and DrVSP. It was found that the first stimulation elicited a biphasic whole-cell current that increased to a final, steady-state value (Figure 4 ). This biphasic kinetics was characterized by τ f of~25 ms and τ s of 620 ms (Figure 4 and Table 3 ). The current amplitude at the initial transient plateau was 85 ± 12 pA/pF (n = 12), and steady-state current at the end of the pulse was 94 ± 12 BJP C M Ta et al. pA/pF (n = 12). In contrast, the subsequent two stimulations elicited currents with a single exponential time course with τ f of~30 ms in each case (Table 3 ). The steady-state current amplitude was 96 ± 13 pA/pF (n = 12) and 97 ± 13 pA/pF (n = 12) for the second and the third pulse, respectively (Figure 4) . We interpreted the biphasic current time course of TMEM16A and TMEM16B currents observed in response to the first stimulation as being the result of the depletion of endogenous PIP 2 by DrVSP. The subsequent stimulations would not manifest these effects, as endogenous PIP 2 would already be depleted. We tested this idea by examining the consequence of co-transfecting TMEM16A or TMEM16B channels with a mutant form of DrVSP, which does not support PIP 2 dephosphorylation (Imai et al., 2012) . This DrVSP has the cysteine at position 302 mutated into serine and was termed DrVSP(C302S). When DrVSP(C302S) was present, each stimulation to +100 mV gave rise to TMEM16A and TMEM16B currents with single exponential kinetics indistinguishable from currents recorded in the absence of DrVSP. The TMEM16A steady-state current amplitude was 355 ± 140 pA/pF (n = 5), 363 ± 144 pA/pF (n = 5) and 364 ± 142 pA/pF (n = 5) for the first, second and third pulse respectively (Figure 4 , Table 3 ). The TMEM16B steady-state current amplitude was 115 ± 17 pA/pF (n = 8), 118 ± 19 pA/pF (n = 8) and 122 ± 20 pA/pF (n = 8) for the first, second and third pulse respectively (Figure 4, Table 3 ).
Combined effects of DrVSP and PIPK on TMEM16A and TMEM16B channels
To further test the hypothesis that the effects of DrVSP on TMEM16A and TMEM16B currents were due to endogenous PIP 2 depletion, cells were co-transfected with either
Figure 4
Effects of DrVSP activation on the kinetics of TMEM16A and TMEM16B currents. Whole-cell currents recorded from HEK-293T cells expressing either TMEM16A or TMEM16B alone, or co-transfected with either DrVSP or DrVSP(C302S), as indicated. [Ca 2+ ] i was 0.3 or 0.6 μM for experiments involving TMEM16A or TMEM16B channels respectively. The stimulation protocol is shown in the top left corner. Each panel represents the current elicited by three consecutive voltage pulses from À100 to +100 mV (inter-pulse duration was 0.5 s). Dashed Red traces represent the monoor bi-exponential fit of the currents elicited by the first pulse. Dashed blue traces represent the mono-exponential fit of the currents elicited by the third pulse. Horizontal dashed black lines represent zero-current levels.
TMEM16A or TMEM16B in conjunction with DrVSP and PIPK. This was done with the rationale that the presence of PIPK would oppose the effect of DrVSP by synthesizing additional PIP 2 . Whole-cell currents were recorded in response to a single depolarizing step to +100 mV for 4 s from a holding potential of À100 mV ( Figure 5A ). These whole-cell currents had kinetics involving multiple components and could not be satisfactorily described by a double exponential function; at least the sum of three exponentials was required to fit these currents (not shown). We measured the extent of DrVSP-mediated inhibition of TMEM16A currents in the absence and presence of PIPK as the ratio between the peak current and the current measured at the end of the depolarizing pulse. This ratio was 0.75 ± 0.03 (n = 14) and 0.90 ± 0.02 (n = 14) in the absence and presence of PIPK respectively ( Figure 5B ). Thus, the presence of PIPK reduced the TMEM16A current inhibition provoked by DrVSP. We also examined the combined effect of DrVSP and PIPK on TMEM16B channels ( Figure 5A ). This was assessed as the ratio of the current measured at the beginning and at the end of the depolarizing pulse. This ratio was 1.12 ± 0.02 (n = 12) and 1.42 ± 0.10 (n = 12) in the absence and presence of PIPK respectively ( Figure 5B ). Thus, an elevated level of PIP 2 caused by PIPK inhibited TMEM16B currents, and this allowed greater scope for activation when the cell was depleted of PIP 2 by DrVSP.
Recovery of the DrVSP-mediated inhibition of TMEM16A and TMEM16B channels
We argued that if the effects of DrVSP on the TMEM16A and TMEM16B currents were due to bona fide depletion of PIP 2 from the plasma membrane of transfected HEK-293T cells, these effects could be replicated if enough time was allowed for PIP 2 synthesis to occur in the cells. This possibility was tested using a double-pulse protocol (see Methods) during whole-cell recordings in cells transfected with TMEM16A or TMEM16B and DrVSP ( Figure 6 ). In these experiments, 1 mM of MgATP was included in the intracellular solution to enable PIP 2 synthesis by endogenous phosphatidylinositol phosphate kinases. Furthermore, the holding potential was maintained at À50 mV, which is close to the resting membrane potential in HEK-293T cells, while also being sufficient to maintain DrVSP inactivated (Okamura et al., 2009) . Figure 6 shows that the DrVSP-mediated modulation of TMEM16A and TMEM16B currents is completely restored after about ≥50 s 'recovery' period at À50 mV. The relationship between the extent of recovery of this effect versus the duration of the time interval spent at À50 mV was characterized by a τ r of 7.2 ± 0.7 s (n = 11) and 10.9 ± 2.5 s (n = 10) (N.S., t-test) for TMEM16A and TMEM16B respectively.
Discussion
The key finding of this study is the observation that PIP 2 provokes opposing effects on TMEM16A and TMEM16B channels, leading to channel activation and inhibition respectively. These modulatory effects of PIP 2 occurred in a concentration range similar to that causing modulation of other ion channel types including, but not limited to, KCNQ (e.g. Zhang et al., 2003; Li et al., 2011 ), K v (e.g. RodriguezMenchaca et al., 2012 and TRPC1 (e.g. Saleh et al., 2009) channels. The extent of PIP 2 modulation of the TMEM16A current varied significantly depending on [Ca 2+ ] i ; in contrast, the extent of modulation of TMEM16B current did not vary over a broad range of [Ca 2+ ] i tested (0.6-2 μM). Furthermore, the effects of PIP 2 on the TMEM16A current were observable at all V m tested, while TMEM16B was only modulated at highly depolarized V m > 50 mV. This suggests that in vivo modulation of TMEM16A currents by PIP 2 may occur under resting conditions as well as at depolarized V m . In contrast, the effect of PIP 2 on TMEM16B may only become relevant in the rare types of excitable cells that reach highly depolarized V m > 50 mV during action potentials.
Modulation of TMEM16A and TMEM16B channels by diC8-PIP 2 A recent study indicated that PIP 2 binds directly to TMEM16A channels (Pritchard et al., 2014) . This study also included functional evidence that PIP 2 inhibited native CaCC currents in isolated rPASMCs. In this published study, however, the functional effects of PIP 2 on cloned TMEM16A channels were Table 3 Parameters obtained from single or double exponential fit of the TMEM16A and TMEM16B currents elicited by three consecutive pulses to +100 mV
Order of the pulse First Second Third not investigated. Thus, we set out to study the extent of modulation of the heterologously expressed TMEM16A channel (and the closely related TMEM16B channel) by diC8-PIP 2 as well as endogenous PIP 2 . The use of heterologous expression systems allows the effects of channel modulation to be examined in the absence of potential additional tissue-specific modulatory pathways. diC8-PIP 2 enhanced cloned TMEM16A currents recorded from excised inside-out patches and depletion of endogenous cellular PIP 2 inhibited whole-cell currents. It is known that TMEM16A is an essential component of CaCC in rPASMCs (Manoury et al., 2010) . However, the possibility that in rPASMCs the TMEM16A channels are associated with endogenous binding partners or combine with other TMEM16 members to form channels with novel regulatory properties cannot be excluded. Thus, cell specific components may be responsible for the differential regulation of TMEM16A channel in PASMCs and heterologous expression systems. At present, it is not known whether TMEM16A in other native cell types, including vascular smooth muscle cells from other circulations, is differentially modulated by PIP 2 .
Defining this could be of considerable importance in understanding how potential pharmacological agents acting on PIP 2 synthesis/depletion may affect TMEM16A in different cell types. A previous study indicated that heterologous whole-cell TMEM16A currents were insensitive to compounds that interfere with inositolphosphates and phosphatidylinositols (Tian et al., 2013) . Our observation that the effects of diC8-PIP 2 on TMEM16A currents were negligible at relative high (>2 μM) [Ca 2+ ] i could explain the lack of effect observed by Tian et al. (2013) . In this study, whole-cell TMEM16A currents were elicited in response to factors that result in high [Ca 2+ ] i such as ionomycin (Morgan and Jacob, 1994) or prolonged exposure of cells to extracellular ATP (Qi et al., 2000) . In our study, we also observed that TMEM16B currents were inhibited by diC8-PIP 2 in the same concentration range that activated TMEM16A. Both changes in TMEM16A and TMEM16B current amplitudes were due to changes in channel gating, while single channel conductance and ion selectivity remained unaltered. Thus, the diC8-PIP 2 acts as a Figure 6 Time course of the recovery of TMEM16A and TMEM16B currents in response to DrVSP activation. (A) Whole-cell currents recorded from HEK-293T cells expressing TMEM16A or TMEM16B, and DrVSP, as indicated. Currents were elicited using the double-pulse protocol described in Methods and illustrated in the top left corner. In each panel, the current elicited by a pre-pulse was superimposed over the current elicited by two test pulses following recovery periods of different durations (3 and 55 s). To facilitate visual comparison, currents were normalized for the steady-state current reached during each pulse. Dashed lines represent zero-current levels. (B) Mean relationship between the extent of recovery of the DrVSP-mediated modulation of the currents and the recovery time. The number of experiments was 11 (for TMEM16A and TMEM16B). The smooth curves through the points represent the best fit of the data with single exponential functions.
gating modifier of cloned TMEM16A and TMEM16B channels.
The concentration range of diC8-PIP 2 that modulated the TMEM16A and TMEM16B currents [1-100 μg·mL
À1
(1.17-117 μM)] is similar to the reported concentration of endogenous PIP 2 . Reported values of membrane PIP 2 concentration include~2-30 μM in cultured cell lines (McLaughlin et al., 2002) ,~50 μM in unstimulated neutrophils (Stephens et al., 1991) or 200 μM in platelets in the resting state (Hartwig et al., 1995) .
Modulation of TMEM16A and TMEM16B channels by endogenous PIP 2
The voltage-sensitive protein phosphatase DrVSP was used to assess the sensitivity of the TMEM16A channel to endogenous PIP 2 . DrVSP is a membrane-resident phosphoinositide 5-phosphatase that enables rapid depletion of PIP 2 content in intact cells when V m is brought from negative to positive values (Okamura et al., 2009) . Specifically, and consistently with the modulatory effects of diC8-PIP 2 in inside-out patches, DrVSP activation reduced the amplitude of TMEM16A currents, whereas TMEM16B current amplitude was increased.
The kinetics of PIP 2 depletion by DrVSP have been investigated using fluorescence resonance energy transfer imaging of PIP 2 levels in HEK-293T cells (Itsuki et al., 2014) . It was shown that within~1 s of activation of the phosphatase, PIP 2 in the membrane was significantly depleted (Itsuki et al., 2014) . This time course of alterations in plasmalemmal PIP 2 content is consistent with the changes in current amplitude we observed in cells expressing TMEM16A or TMEM16B channels and DrVSP. The effects of DrVSP on TMEM16A and TMEM16B currents were abolished when a second depolarizing pulse was elicited after~0.5 s. We interpret this loss of modulation as due to the fact that PIP 2 has been depleted during the first pulse. Consistent with this idea was the fact that the DrVSP-dependent modulations of TMEM16A and TMEM16B currents were fully re-established after~55 s at À50 mV. This duration corresponds to the estimated time of PIP 2 re-synthesis by endogenous PIPK (Loew, 2007; Falkenburger et al., 2010; Itsuki et al., 2014) .
The reduction in the effects of DrVSP on TMEM16A currents caused by overexpression of PIPK is qualitatively consistent with an increased amount of PIP 2 being present in the cell. On the other hand, the increased basal amount of PIP 2 might have rendered the effects of DrVSP on TMEM16B more pronounced: a higher initial extent of current inhibition caused by increased basal levels of PIP 2 would provide greater scope for current activation following DrVSP activation.
Towards the identification of PIP 2 binding site(s) in TMEM16A and TMEM16B channels
The TMEM16A or TMEM16B current versus [diC8-PIP 2 ] relationships we have determined do not provide a direct indication of diC8-PIP 2 affinity. The mid-points of these curves are presumably influenced by competition between diC8-PIP 2 and endogenous PIP 2 , the exact concentration of which was unknown. The parameters j and h of the Hill fit of these relationships equalled~1 in each case, which may be suggestive of a similar number of diC8-PIP 2 molecules binding to the TMEM16A and TMEM16B channels.
In general, PIP 2 modulates ion channels by binding to a diverse range of recognition domains, albeit with different specificities and potencies (Lemmon, 2003; Gamper and Shapiro, 2007; Huang, 2007; Hansen, 2015; Hille et al., 2015) . Recognition domains include pleckstrin homology domains, myristoylated alanine-rich C-kinase substrate domains, phox homology domains, FYVE zinc finger domains, epsin N-terminal homology domains and 4.1 protein-ezrinradixin-moesin domains. These domains differ significantly in structural conformation, size and specificity (Lemmon, 2003; Gamper and Shapiro, 2007; Huang, 2007; Hansen, 2015; Hille et al., 2015) . The precise set of residues involved in PIP 2 binding cannot be directly identified through analysis of the TMEM16A and TMEM16B primary structure. This is because typically PIP 2 binding sites involve residues that are distant in protein primary structures but may be positioned next to each other in their tertiary structures. Understanding the structural determinants of TMEM16A and TMEM16B channels involved in PIP 2 binding will be an important pursuit for future research.
Pharmacological and pathophysiological significance
The extent to which PIP 2 modulation of TMEM16A or TMEM16B channels affects the cell electrical activity may vary depending on the cell type. Factors that may determine the impact of this modulation on cell electrical activity may include (1) the proximity of TMEM16A or TMEM16B channels to cellular mechanisms that determine membrane PIP 2 contents (such as PLC or PIPK), the abundance and distribution of which may vary from cell type to cell type and (2) the contribution that TMEM16A or TMEM16B channels play to the electrical activity of an individual cell type, which may depend on factors such as channel expression and the complement of other transport mechanisms being present.
PIP 2 levels are dynamically regulated in living cells, depending on the extent of PIP 2 -depleting and PIP 2 -synthesizing mechanisms. For example, muscarinic stimulation of sympathetic neurons leads to significant dynamic variations in PIP 2 levels (Kruse et al., 2016) . It is noteworthy that in some cell types, such as mouse portal vein smooth muscle cells, TMEM16A appear to localize in caveolin-1 containing plasma membrane lipid rafts (Sones et al., 2010) . These are regions of the membrane that also tend to concentrate a variety of receptors, including GPCRs (Insel and Patel, 2009) . Furthermore, in cell types such as nociceptive sensory neurons, TMEM16A localized to the same membrane fraction as GPCRs such as the bradykinin B 2 receptor, protease-activated receptor PAR2 and also with caveolin-1, a lipid raft marker (Jin et al., 2013) . Thus, in these cell types, TMEM16A may be surrounded by a local membrane environment in which changes in PIP 2 concentration may vary dynamically in the immediate vicinity of the TMEM16A channel.
Interfering pharmacologically with PIP 2 signalling could lead to modulation of TMEM16A or TMEM16B channel activity. Pharmacological modulators of TMEM16A and TMEM16B channels would constitute important tools for scientific research and potentially for therapeutic treatment of BJP C M Ta et al.
conditions associated with altered Cl À transport. For instance, TMEM16A channels have been proposed as possible therapeutic targets for respiratory diseases of impaired mucus clearance, including cystic fibrosis, chronic obstructive pulmonary disease and asthma (Huang et al., 2012b; Sondo et al., 2014; Sala-Rabanal et al., 2015) . The importance of TMEM16A in epithelial cell function is emphasized by the observation that mice in which the TMEM16A gene has been deleted show a strongly reduced Ca 2+ -dependent Cl À secretion, accumulation of mucus in the airways and impaired mucociliary transport (Ousingsawat et al., 2009; Rock et al., 2009) . Furthermore, Th-2 cytokines-driven goblet cell hyperplasia, a feature of asthma and other respiratory diseases, leads to alteration of TMEM16A expression in human cells and consequent alteration in bicarbonate transport; this in turn affects mucus properties (Gorrieri et al., 2016) . TMEM16A channels are also abundantly expressed in arterial smooth muscle. Overexpression of TMEM16A has been reported in pulmonary arteries during pulmonary hypertension (Sun et al., 2012) , and up-regulation of Cl À currents has been implicated in the proliferation of PASMCs (Liang et al., 2009) . Thus, agents that reduce TMEM16A activity could be beneficial in treating pulmonary hypertension by inducing smooth muscle relaxation and possibly by reducing cell proliferation. We have shown that PIP 2 modulates TMEM16B channels, which are especially relevant in hippocampal neurons (Huang et al., 2012c) , olfactory neurons and photoreceptors (Stephan et al., 2009; Stohr et al., 2009; Hengl et al., 2010; Pietra et al., 2016) . In these cell types, however, the peak of the action potential does not overshoot the 50 mV. Thus, PIP 2 modulation in these cells is unlikely to occur under physiological conditions. TMEM16B is also expressed in DRG neurons (Zhao et al., 2016) , which reportedly are characterized by a peak of AP of~55 mV, and this value may be slightly elevated in the presence of gain-of-function mutations in voltage-gated sodium (Na v ) channels (Dib-Hajj et al., 2008; Hoeijmakers et al., 2012) . Elevation of the peak of action potential might also occur during hypernatraemia, which shifts the Na + equilibrium potential towards higher values. It is conceivable that gain-of-function mutations in voltage-gated calcium (Ca v ) channels might also be associated with an increased action potential peak. Thus, potential PIP 2 -mimicking drugs might interfere with TMEM16B channels under these types of pathological conditions and might be an important consideration in terms of safety pharmacology under these special circumstances.
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